Evaluation of the effect of low-intensity rhythmic transcranial magnetic stimulation on motor and non-motor manifestations of Parkinson's disease
- Authors: Borodulina I.V.1, Gerasimenko M.Y.1
-
Affiliations:
- Russian Medical Academy of Continuous Professional Education
- Issue: Vol 21, No 2 (2022)
- Pages: 115-121
- Section: Original studies
- URL: https://rjpbr.com/1681-3456/article/view/109139
- DOI: https://doi.org/10.17816/rjpbr109139
- ID: 109139
Cite item
Abstract
BACKGROUND: The use of repetitive transcranial magnetic stimulation as a method of non-drug therapy of Parkinson's disease has been actively studied over the past decades. The prevailing number of repetitive transcranial magnetic stimulation protocols in Parkinson's disease use a high intensity of stimulation (80–120% of the value of the threshold of the evoked motor threshold from the muscles of the hand), while the choice of the stimulation intensity parameter was carried out empirically.
AIM: to study the effectiveness of low-intensity unilateral repetitive transcranial magnetic stimulation on motor and non-motor symptoms of Parkinson's disease.
MATERIAL AND METHODS:An open prospective non-randomized clinical trial included 37 patients with stage I–III Parkinson's disease according to Hoehn–Yahr (1967), akinetic-rigid and mixed (akinetic-rigid-tremor) forms. All patients underwent repetitive transcranial magnetic stimulation according to the protocol: M1 stimulation zone, frequency 5 Hz, intensity 40% of the cortical motor threshold, on 6s, off 8s, total number of pulses per session 3000. The course of treatment is 10 procedures with 2 days (weekend) off.
RESULTS: All patients completed the study in accordance with the protocol. When analyzing the results of the UPDRS scale (Unified Parkinson's disease rating scale), positive dynamics was noted in all parts of the questionnaire: part I ― from 2 (0; 3) to 0 (0; 1) points, p <0.05; part II ― from 9 (5.5; 12.5) to 4 (2; 6.5) points, p <0.05; part III ― with 11 (7; 14.5) to 6 (2; 7.5) points, p <0.05; part IV (Schwab and England scale) ― from 80% (70; 95) to 90% (85; 100), p <0.05. There was also a selective effect on non-motor symptoms.
CONCLUSION: Low-intensity exposure (40% of the motor threshold) has a significant clinical effect on motor and non-motor symptoms of Parkinson's disease; stimulation of the primary motor cortex can have an antidepressant effect; repetitive transcranial magnetic stimulation has a selective effect on non-motor symptoms of Parkinson's disease: a predominant effect has been demonstrated with respect to olfactory, emotional, cognitive disorders, sleep disorders and hypersalivation; when assessing the dynamics of motor disorders, a more pronounced effect was noted with respect to rigidity, postural disorders, walking speed, and to a lesser extent, the effect on tremor was noted.
Full Text
About the authors
Irina V. Borodulina
Russian Medical Academy of Continuous Professional Education
Author for correspondence.
Email: irina.borodulina@gmail.com
ORCID iD: 0000-0001-7526-1553
SPIN-code: 2152-5737
MD, Cand. Sci. (Med.), Assistant
Russian Federation, MoscowMarina Yu. Gerasimenko
Russian Medical Academy of Continuous Professional Education
Email: mgerasimenko@list.ru
ORCID iD: 0000-0002-1741-7246
SPIN-code: 7625-6452
MD, Dr. Sci. (Med.), Professor
Russian Federation, MoscowReferences
- Strafella AP, Vanderwerf Y, Sadikot AF. Transcranial magnetic stimulation of the human motor cortex influences the neuronal activity of subthalamic nucleus. Eur J Neurosci. 2004;20(8):2245–2249. doi: 10.1111/j.1460-9568.2004.03669.x
- Lefaucheur JP. Repetitive transcranial magnetic stimulation (rTMS): insights into the treatment of Parkinson's disease by cortical stimulation. Neurophysiol Clin. 2006;36(3):125–133. doi: 10.1016/j.neucli.2006.08.003
- Sommer M, Kamm T, Tergau F, et al. Repetitive paired-pulse transcranial magnetic stimulation affects corticospinal excitability and finger tapping in Parkinson’s disease. Clin Neurophysiol. 2002;113(6):944–950. doi: 10.1016/s1388-2457(02)00061-5
- Rothkegel H, Sommer M, Rammsayer T, et al. Training effects outweigh effects of single-session conventional rTMS and theta burst stimulation in PD patients. Neurorehabil Neural Rep. 2009;23(4):373–381. doi: 10.1177/1545968308322842
- Siebner HR, Mentschel C, Auer C, et al. Repetitive transcranial magnetic stimulation causes a short-term increase in the duration of the cortical silent period in patients with Parkinson’s disease. Neurosci Lett. 2000;284(3):147–150. doi: 10.1016/s0304-3940(00)00990-3
- Khedr EM, Rothwell JC, Shawky OA, et al. Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson’s disease. Mov Disord. 2006;21(12):2201–2205. doi: 10.1002/mds.21089
- Maruo T, Hosomi K, Shimokawa T, et al. Highfrequency repetitive transcranial magnetic stimulation over the primary foot motor area in Parkinson’s disease. Brain Stimul. 2013;6(6):884–891. doi: 10.1016/j.brs.2013.05.002
- González-Garcıá N, Armony JL, Soto J, et al. Effects of rTMS on Parkinson’s disease: a longitudinal fMRI study. J Neurol. 2011;258(7):1268–1280. doi: 10.1007/s00415-011-5923-2
- Zanjani A, Zakzanis KK, Daskalakis ZJ, Chen R. Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson's disease: A quantitative review of the literature. Mov Disord. 2015;30(6):750–758. doi: 10.1002/mds.26206
- Lefaucheur JP, André-Obadia N, Antal A, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125(11):2150–2206. doi: 10.1016/j.clinph.2014.05.021
- Makkos A, Pál E, Aschermann Z, et al. High-Frequency repetitive transcranial magnetic stimulation can improve depression in parkinson’s disease: a randomized, double-blind, placebo-controlled study. Neuropsychobiology. 2016;73(3):169–177. doi: 10.1159/000445296
- Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014–2018). Clin Neurophysiol. 2020;131(2):474–528. doi: 10.1016/j.clinph.2019.11.002
- Brys M, Fox MD, Agarwal S, et al. Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trial. Neurology. 2016;87(18):1907–1915. doi: 10.1212/WNL.0000000000003279
- Chung CL, Mak MK, Hallett M. Transcranial magnetic stimulation promotes gait training in parkinson disease. Ann Neurol. 2020;88(5):933–945. doi: 10.1002/ana.25881
- Nardone R, Versace V, Brigo F, et al. Transcranial magnetic stimulation and gait disturbances in Parkinson's disease: A systematic review. Neurophysiol Clin. 2020;50(3):213–225. doi: 10.1016/j.neucli.2020.05.002
- Kashezhev A, Sinkin M, Kulikov A, Levin O. Impact of rhythmic transcranial magnetic stimulation on the dynamics of motor and non-motor manifestations of Parkinson's disease. Vopr Kurortol Fizioter Lech Fiz Kult. 2019;96(6):17–21. (In Russ). doi: 10.17116/kurort20199606117
- Lamusuo S, Hirvonen J, Lindholm P, et al. Neurotransmitters behind pain relief with transcranial magnetic stimulation ― positron emission tomography evidence for release of endogenous opioids. Eur J Pain. 2017;21(9):1505–1515. doi: 10.1002/ejp.1052
- Ilmoniemi RJ, Virtanen J, Ruohonen J, et al. Neuronal responses to magnetic stimulation reveal cortical reactivity and connectivity. Neuroreport. 1997;8(16):3537–3540. doi: 10.1097/00001756-199711100-00024
- Pellegrini M, Zoghi M, Jaberzadeh S. Can genetic polymorphisms predict response variability to anodal transcranial direct current stimulation of the primary motor cortex? Eur J Neurosci. 2021;53(5):1569–1591. doi: 10.1111/ejn.15002